Overall Sector and Industry Analysis
- Datetime range analyzed (EST): 2025-11-21, 09:30 to 12:00, using 30-minute bars from the data provided. Note: Only intraday data for this session was provided; 30-day context is inferred from current momentum and typical ATR behavior.
-
Broad read:
- Healthcare led across sub-groups: tools/instruments and services broke higher (TMO, DHR, WAT, IQV, DGX, LH), managed care and providers advanced (UNH, HCA, CI), and biotech risk appetite picked up (LABU, DNLI, TXG, CTKB, TRDA, STOK, DNTH, ERAS).
- Consumer discretionary showed strong rotation: beauty and off-price retail outperformed (ULTA, BURL), e-commerce rallied (W).
- Tech/internet infrastructure and software firmed (VRSN, AKAM, FICO, CPAY, QTWO, QXO; YOU also strong).
- Industrials bid (DE, FDX grinding higher).
- Materials/chemicals constructive (SHW breakout; APD reclaim; LIN steady).
- Small/mid-cap momentum pockets: CELC, ALMS, BBNX, DNLI, TXG, WALD posted range expansions with rising volume.
- Notable intraday patterns:
- Multiple large caps broke morning highs with rising volume into late morning, a classic day-1 momentum signature that often carries 1–3 days.
- Strong breadth within healthcare suggests sector-level tailwind; discretionary strength into the holiday window adds a seasonality bid.
- Many names closed their morning session near HOD with shallow pullbacks (continuation-friendly tape). Tickers exemplifying this: TMO, ULTA, IQV, VRSN, BURL, W, DNLI, TXG, DHR, WAT, UNH.
Ticker Performance Prediction (next 2–3 days)
- Highest-probability upside continuations:
- TMO, ULTA, IQV, VRSN, W, BURL, DNLI, CPAY, TXG, DHR, HCA, WAT, UNH, CELC.
- Strongest bullish signals observed:
- Breakout-and-hold above morning highs with volume expansion (TMO, ULTA, IQV, DHR, HCA).
- Higher-high/higher-low sequences across successive 30-min bars into midday (VRSN, W, BURL, CPAY, TXG, DNLI).
- Relative strength vs sector peers and closes near HOD (WAT, UNH).
Individual Stock Analysis
(Levels reference recent supply/demand zones and obvious psych levels; refine with your daily chart. Targets approximate 1–3 day ATR potential from current momentum.)
1) TMO
– Why bullish: Clean breakout from 576.6 with rising volume; close near HOD.
– Support: 580.0; 576.6; 571.7.
– Resistance: 585.0; 590.0; 600.0.
– Next 2–3 days (30-min path): Prefer a pullback-to-hold at 580–576, then a push through 585 toward 590; momentum tape could squeeze to 595–600 if volume persists.
– Entries: 580–581 first buy; add 576.8–577.5 on strong hold.
– Stop-loss: 571.5 (decisive loss of breakout base).
– Price targets: 588–590; 595–596; stretch 600–602.
–
2) ULTA
– Why bullish: Trend day up; held gains; discretionary bid strong.
– Support: 520.0; 518.6; 515.0.
– Resistance: 525.0; 530.0; 535.0.
– Next 2–3 days: Look for a 520 retest and curl; break/hold 525 opens 530 then 534–535.
– Entries: 520–521; secondary 518.8 on tight risk.
– Stop-loss: 514.8 (below demand and morning structure).
– Price targets: 528–530; 534–535; stretch 538–540.
–
3) IQV
– Why bullish: Multi-hour trend with higher highs; strong within healthcare services.
– Support: 222.0; 221.3; 220.5.
– Resistance: 225.0; 227.0–227.5; 229.5–230.0.
– Next 2–3 days: Prefer 222–223 coil then 225 breakout to 227–228; if tape remains risk-on, 230 test.
– Entries: 222.2–223.0 on dip/hold; momentum add on clean 225 break.
– Stop-loss: 220.8 (below pivot).
– Price targets: 225.8–226.5; 227.3–228.0; 229.5–230.0.
–
4) VRSN
– Why bullish: Range expansion, steady accumulation; close near highs.
– Support: 252.5; 251.9; 250.9.
– Resistance: 255.0; 257.0; 260.0.
– Next 2–3 days: Dip to 253 then push to 255–257; grindy name but can stair-step to 259–260 on follow-through.
– Entries: 252.8–253.2.
– Stop-loss: 251.5.
– Price targets: 255.5; 257.0–257.5; 259.5–260.0.
–
5) W (Wayfair)
– Why bullish: Strong intraday reversal and extension; discretionary group strength.
– Support: 104.0; 103.65; 102.2.
– Resistance: 106.0; 108.0; 110.0.
– Next 2–3 days: Base above 104 then attempt 106 breakout; if volume rotates in, 108 tag possible; extended name can be volatile.
– Entries: 104.3–104.7.
– Stop-loss: 103.4 (below pivot cluster).
– Price targets: 106.2; 108.0; stretch 109.8–110.2.
–
6) BURL
– Why bullish: Persistent push, closing near HOD; off-price retail bid.
– Support: 292.0; 291.1; 287.8.
– Resistance: 297.0; 300.0; 305.0.
– Next 2–3 days: Expect a 292–293 dip/hold, then 297 test; a clean 300 break can accelerate to 304–305.
– Entries: 292.5–293.5.
– Stop-loss: 290.9.
– Price targets: 297.5–298.0; 300.5–301.0; 304–305.
–
7) DNLI
– Why bullish: Biotech momentum expanding; sharp volume on breakout bar to 18.21.
– Support: 17.70; 17.45; 17.25.
– Resistance: 18.25; 18.60; 19.00.
– Next 2–3 days: Favored path is pullback to 17.8–17.9, then 18.25 breakout; if risk-on persists, 18.6 then 18.9–19.
– Entries: 17.75–17.85.
– Stop-loss: 17.45 (loss of breakout).
– Price targets: 18.30–18.40; 18.60; 18.90–19.00.
–
8) CPAY
– Why bullish: Payments strength; stair-step higher with HOD close.
– Support: 287.0; 285.0; 282.95.
– Resistance: 290.0; 293.0–294.0; 296.0–297.0.
– Next 2–3 days: Prefer a 286.5–287 backfill, then 290 breakout toward 293–294; continuation could press 296–297.
– Entries: 286.5–287.2.
– Stop-loss: 285.2.
– Price targets: 290.0–291.0; 293.5–294.0; 296.0–297.0.
–
9) TXG
– Why bullish: Clear range expansion; life-science tools bid in sync with TMO/DHR/WAT.
– Support: 17.48; 17.15; 16.95.
– Resistance: 18.20; 18.50; 19.00.
– Next 2–3 days: A 17.55–17.7 hold should set up an 18.2 retest; continuation to 18.5 possible with sector tailwind.
– Entries: 17.55–17.70.
– Stop-loss: 17.40.
– Price targets: 18.20; 18.50; 18.90.
–
10) DHR
– Why bullish: Strong impulse move and hold above 227; leadership within tools.
– Support: 225.3; 224.3; 223.9.
– Resistance: 227.5–228.0; 230.0; 232.0.
– Next 2–3 days: Expect a 225.8–226.5 check-back then 228 retest; break/hold opens 230–232.
– Entries: 225.8–226.5.
– Stop-loss: 223.8.
– Price targets: 228.0–228.8; 230.0–231.0; 231.8–232.5.
–
Risk management notes
– Many names closed the morning near HOD after multi-bar runs; first pullback entries toward prior breakout levels (and VWAP on your intraday) are preferable to chasing.
– Use position sizing aligned with the distance to your invalidation; tighten stops if the market loses sector breadth (especially in biotech where moves are amplified).
– If broader tape weakens, trail stops to breakeven as first targets are hit.
If you’d like, share full daily OHLCV or 30-day ATRs and I’ll refine levels/targets with higher precision.